DRUG DISTRIBUTION RESTRICTIONS

Summary

The bill amends the Wholesale Drug Distribution Licensing Act so that manufacturers and wholesale distributors may ship prescription drugs only to a licensee’s registered business address, the address on their license, or to a health‑care entity the licensee has authorized. It also adds rules for drug returns, recipient verification, hospital pharmacy deliveries, and who can be listed on purchase accounts. The goal is to tighten control of the drug supply chain and reduce the risk of counterfeit or mishandled medications.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share